Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Tjong

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Oncotarget|October 17, 2022
Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysisMichael Jonathan Kucharczyk, Andrew Bang, Michael C Tjong, et al.
Neurosurgery|July 25, 2023
Reduced Mortality and Radiation Necrosis After Surgery With Postoperative Stereotactic Radiation in Patients With Multiple Brain MetastasesVarun M Bhave, Nayan Lamba, Michael C Tjong, et al.
Surgical Oncology Clinics of North America|May 14, 2023
Advances in MRI-Guided Radiation TherapyMichael D Chuong, Russell F Palm, Michael C Tjong, et al.
Translational Lung Cancer Research|August 25, 2021
Local ablative therapies in oligometastatic NSCLC-upfront or outback?-a narrative reviewMichael C Tjong, Alexander V Louie, Puneeth Iyengar, et al.
Frontiers in Oncology|August 8, 2020
Current Management and Progress in Radiotherapy for Small Cell Lung CancerMichael C Tjong, David Y Mak, Jeevin Shahi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 19, 2022
Major adverse cardiac event risk prediction model incorporating baseline Cardiac disease, Hypertension, and Logarithmic Left anterior descending coronary artery radiation dose in lung cancer (CHyLL)Michael C Tjong, Danielle S Bitterman, Kristen Brantley, et al.
Current Oncology (Toronto, Ont.)|January 20, 2022
Safety Related to the Timing of Radiotherapy and Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer: A Single Institutional ExperienceMichael C Tjong, Malavan Ragulojan, Ian Poon, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|May 5, 2016
The Perceptions and Expectations of Older Women in the Establishment of the Senior Women's Breast Cancer Clinic (SWBCC): a Needs Assessment StudyMichael C Tjong, Ines Menjak, Maureen Trudeau, et al.
Journal of Thoracic Disease|July 10, 2020
Stereotactic ablative radiotherapy for malignant mediastinal and hilar lymphadenopathy: a systematic reviewMichael C Tjong, Nauman H Malik, Hanbo Chen, et al.
Scientific Reports|March 7, 2018
Radiomics analysis at PET/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapyAnastasia Oikonomou, Farzad Khalvati, Pascal N Tyrrell, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Oncotarget|October 17, 2022
Effectiveness of radiotherapy for local control in T3N0 rectal cancer managed with total mesorectal excision: a meta-analysisMichael Jonathan Kucharczyk, Andrew Bang, Michael C Tjong, et al.
Neurosurgery|July 25, 2023
Reduced Mortality and Radiation Necrosis After Surgery With Postoperative Stereotactic Radiation in Patients With Multiple Brain MetastasesVarun M Bhave, Nayan Lamba, Michael C Tjong, et al.
Surgical Oncology Clinics of North America|May 14, 2023
Advances in MRI-Guided Radiation TherapyMichael D Chuong, Russell F Palm, Michael C Tjong, et al.
Translational Lung Cancer Research|August 25, 2021
Local ablative therapies in oligometastatic NSCLC-upfront or outback?-a narrative reviewMichael C Tjong, Alexander V Louie, Puneeth Iyengar, et al.
Frontiers in Oncology|August 8, 2020
Current Management and Progress in Radiotherapy for Small Cell Lung CancerMichael C Tjong, David Y Mak, Jeevin Shahi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 19, 2022
Major adverse cardiac event risk prediction model incorporating baseline Cardiac disease, Hypertension, and Logarithmic Left anterior descending coronary artery radiation dose in lung cancer (CHyLL)Michael C Tjong, Danielle S Bitterman, Kristen Brantley, et al.
Current Oncology (Toronto, Ont.)|January 20, 2022
Safety Related to the Timing of Radiotherapy and Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer: A Single Institutional ExperienceMichael C Tjong, Malavan Ragulojan, Ian Poon, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|May 5, 2016
The Perceptions and Expectations of Older Women in the Establishment of the Senior Women's Breast Cancer Clinic (SWBCC): a Needs Assessment StudyMichael C Tjong, Ines Menjak, Maureen Trudeau, et al.
Journal of Thoracic Disease|July 10, 2020
Stereotactic ablative radiotherapy for malignant mediastinal and hilar lymphadenopathy: a systematic reviewMichael C Tjong, Nauman H Malik, Hanbo Chen, et al.
Scientific Reports|March 7, 2018
Radiomics analysis at PET/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapyAnastasia Oikonomou, Farzad Khalvati, Pascal N Tyrrell, et al.
Pageof 3